Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Clinical Pharmacology in Drug Development|April 30, 2016
No influence of the CYP2C19-selective inhibitor omeprazole on the pharmacokinetics of the dopamine receptor agonist rotigotineJan-Peer Elshoff, Willi Cawello, Jens-Otto Andreas, et al.
Journal of Clinical Pharmacology|July 25, 2009
Lack of pharmacokinetic interactions between transdermal rotigotine and oral levodopa/carbidopaMarina Braun, Willi Cawello, Jens-Otto Andreas, et al.
British Journal of Clinical Pharmacology|June 29, 2011
Single dose pharmacokinetics of the transdermal rotigotine patch in patients with impaired renal functionWilli Cawello, Sascha Ahrweiler, Wladyslaw Sulowicz, et al.
Epilepsia|April 26, 2013
Lack of effect of lacosamide on the pharmacokinetic and pharmacodynamic profiles of warfarinArmel Stockis, Jan Jaap van Lier, Willi Cawello, et al.
Epilepsia|May 20, 2015
Comparison of lacosamide concentrations in cerebrospinal fluid and serum in patients with epilepsyTheodor W May, Christian Brandt, Renate Helmer, et al.
Clinical Pharmacokinetics|September 15, 2007
Transdermal administration of radiolabelled [14C]rotigotine by a patch formulation: a mass balance trialWilli Cawello, Hans Michael Wolff, Wim J A Meuling, et al.
Pageof 4